Concepedia

Anna Israyelyan

AI

Statistics

Publications

4

Citations

101

H-Index

4

Active since

2007

Affiliations

Louisiana State University(Current)

Anna Israyelyan is an author at Louisiana State University specializing in oncology, molecular oncology, and oncogenic viruses.

Publications per year

2007–2014

4

Publications

4

Real-time assessment of relapse risk based on the WT1 marker in acute leukemia and myelodysplastic syndrome patients after hematopoietic cell transplantation

Anna Israyelyan, Leanne Goldstein, Wei Yann Tsai et al. · Bone Marrow Transplantation · 2014 · 31 citations · Full text

Medicine, Hematology, Oncology +16

Herpes simplex virus type-1(HSV-1) oncolytic and highly fusogenic mutants carrying the NV1020 genomic deletion effectively inhibit primary and metastatic tumors in mice

Anna Israyelyan, Vladimir N. Chouljenko, Abolghasem Baghian et al. · Virology Journal · 2008 · 28 citations · Full text

Life Sciences, Molecular Biology, Oncology +15

Effective Treatment of Human Breast Tumor in a Mouse Xenograft Model with Herpes Simplex Virus Type 1 Specifying the NV1020 Genomic Deletion and the gBsyn3 Syncytial Mutation Enabling High Viral Replication and Spread in Breast Cancer Cells

Anna Israyelyan, Jeffrey M. Melancon, Larry G. Lomax et al. · Human Gene Therapy · 2007 · 23 citations

Life Sciences, Molecular Biology, Oncology +16

Thalidomide suppressed the growth of 4T1 cells into solid tumors in Balb/c mice in a combination therapy with the oncolytic fusogenic HSV-1 OncdSyn

Anna Israyelyan, Edward John Shannon, Abolghasem Baghian et al. · Cancer Chemotherapy and Pharmacology · 2009 · 19 citations

Medicine, Oncology, Pharmacology +16

1–4 of 4